Financial Gravity Companies’s Novo Nordisk NVO Stock Holding History

Financial Gravity Companies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Buy	+54,637	New	+$2.35M	0.43%	54
2025 Q2	$2.04M	Buy	+29,546	New	+$2.01M	0.4%	65
2024 Q4	$1.92M	Buy	22,321 +2,051	+10%	+$222K	0.44%	56
2024 Q3	$2.41M	Buy	+20,270	New	+$2.7M	0.65%	34
2018 Q4	$5K	Buy	+220	New	+$4.89K	﹤0.01%	718
2018 Q1	$6K	Sell	238 -92	-28%	-$2.42K	0.01%	682
2017 Q4	$9K	Buy	+330	New	+$8.39K	0.01%	585

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Financial Gravity Companies's NVO Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in Novo Nordisk (NVO) in Q2 2026: 54,637 shares worth $2.62M. The stake represents 0.43% of the portfolio and ranks #54 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in NVO as recently as Q2 2025.

Financial Gravity Companies first reported a position in NVO in Q4 2017 and has held it in 7 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Financial Gravity Companies held 54,637 shares of Novo Nordisk worth $2.62M as of Q2 2026.
Novo Nordisk was a new Financial Gravity Companies position in Q2 2026.
Novo Nordisk made up 0.43% of Financial Gravity Companies's portfolio in Q2 2026, its #54 holding.
Financial Gravity Companies first reported a position in Novo Nordisk in Q4 2017 and has held it in 7 quarters since.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.